Related Experiment Video
Updated: Jun 8, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Laboratory markers of coagulation activation
1Department of Medicine, Beth Israel Hospital, Boston, MA 02215.
Biochemical markers can detect imbalances in blood coagulation before thrombosis occurs. Further research is needed to confirm if these assays can identify individuals at risk for hypercoagulable states and guide preventative therapy.
Area of Science:
- Biochemistry
- Hematology
- Clinical Pathology
Background:
- Hemostasis involves complex procoagulant and anticoagulant mechanisms.
- Advances in biochemistry enable sensitive measurement of coagulation system activation markers.
- Biochemical imbalances may precede clinical thrombotic events.
Purpose of the Study:
- To assess the utility of novel biochemical markers in detecting hypercoagulable states.
- To explore the potential of these markers for early identification of thrombotic risk.
- To evaluate the feasibility of preemptive therapeutic intervention based on biochemical assays.
Main Methods:
- Development of sensitive assays for peptides, enzyme-inhibitor complexes, and enzymes.
- Measurement of these markers in human blood samples.
- Analysis of biochemical markers in relation to thrombotic phenomena.
Main Results:
- Biochemical imbalances between procoagulant and anticoagulant mechanisms are detectable in vivo.
- These imbalances can be identified prior to the clinical manifestation of thrombosis.
- Current assay techniques show promise for identifying hypercoagulable states.
Conclusions:
- Biochemical markers offer a potential window into pre-thrombotic states.
- Prospective studies are essential to validate these assays for clinical risk stratification.
- Early detection may enable timely intervention to prevent thrombotic disease.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...